Windgap Medical, Inc.

Windgap Medical, Inc. (Watertown, MA) is a rapidly growing, private pharmaceutical company developing injection devices for self-administration and associated drugs. Windgap’s first product is a novel autoinjector that delivers a proprietary epinephrine formulation for the treatment of anaphylactic shock. This new epinephrine product provides users with a thermally stable drug, smaller device, and simpler use case compared to market competitors. Windgap’s current delivery platform and others in development will be used to expand the company’s portfolio of products.